-
Qualitest gets FDA OK for generic Keppra XR
HUNTSVILLE, Ala. — Qualitest Pharmaceuticals announced that it has received approval from the Food and Drug Administration for its generic version of an epilepsy treatment.
The drug maker said its abbreviated new drug application for levetiracetam extended-release tablets, in the 500-mg and 750-mg strength, was approved. The drug is a generic version of UCB's Keppra XR.
Total combined sales for levetiracetam extended-release tablets were approximately $124.8 million for the 12 months ended in May, according to IMS Health data.
-
Sagent launches generic antibiotic
SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a generic antibiotic, the company said.
The generic drug maker announced the launch of oxacillin for injection. The drug is a semi-synthetic penicillin used to treat infections caused by penicillinase-producing staphylococci bacteria that have demonstrated susceptibility to the drug.
The drug had sales of $29 million during the 12-month period ended in May, according to IMS Health.